ThePharmyard Click here to see all Palgrave Macmillan titles in ThePharmYard
Pay-as-you-go medical and pharmaceutical industry information About Us | Contact Us | Terms
The Publishers

Competition aspects of pharmaceutical patent settlements and licences in Australia

This expert article was written by Wayne Condon and first published in Journal of Generic Medicines, Volume 5, Number 2, January 2008

Product Details - See below for further product information
Note the document you buy is licensed for your own use only.

File type and size: PDF 0.066 MB
Publication size: 5 pages
Publication date: January 2008
Published by: Palgrave Macmillan Publishing
ThePharmYard product code: palgrave203

Our Price: £16.00
You are buying an e-document. This is a digital product and therefore UK VAT @ 17.50 % will be added at Checkout if your billing address is in the EU.

Related Products:

Further Product Information

AUTHOR(S):

Wayne Condon is a partner at Australian law and patent attorney firm Griffith Hack. He specialises in advising generic pharmaceutical companies on patent, regulatory and competition issues. Griffith Hack provides a full range of IP services for biotech and pharmaceutical companies from patent drafting and prosecution to licensing and patent litigation.

ABSTRACT

This paper provides an overview of the competition law (antitrust) issues surrounding the licensing of patented technology in Australia, including licences granted to settle patent litigation. Compliance within Australian competition law in the context of IP licensing is likely to assume greater importance in light of the projected tightening of safe harbour provisions.



ABOUT THE JOURNAL

Journal of Generic Medicines

ISSN: 1741-1343

The Journal of Generic Medicines is guided by its respected Editor Greg Perry (European Generic Medicines Association) and an international Editorial Board of leading practitioners and Association representatives from the generics industry.

Journal of Generic Medicines is the major, international business journal written by and for expert analysis, briefings and legal updates on all aspects of business development, regulatory affairs, manufacturing and marketing affecting the generic pharmaceutical industry. Each quarterly issue publishes analyses, briefings and updates which are of direct relevance to practitioners and that meet the highest intellectual standards.

Affiliates | About Us | Contact Us | Terms

ThePharmYard is an initiative for the international medical and pharmaceutical industries from NetworkPharma Ltd. Copyright 2010

Other services managed by NetworkPharma: [www.EuropeanCMEforum.eu] [www.KeywordPharma.com] [www.MedCommsForum.com] [www.MedCommsNetworking.co.uk] [www.NetworkPharma.tv] [www.ThePublicationPlan.com]

We accept the following credit and debit cards: amex visa visa_delta visa_electron mastercard switch jcb solo